Toolkit: Reducing Repeat Operations for Women with Breast Cancer

Sample Performance Reports

Action Plan

  • Action plan worksheets created specifically for the Breast Cancer initiative that can be used to improve prioritization of initiative guideline components and set project goals.

Recommended Readings

Havel, L., Naik, H., Ramirez, L., Morrow, M., & Landercasper, J. (n.d.). Impact of the SSO-ASTRO Margin Guideline on Rates of Re-excision After Lumpectomy for Breast Cancer: A Meta-analysis. Annals of Surgical Oncology., Annals of surgical oncology. , 201 

Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22(10):3174–3183.

Houssami N, Macaskill P, Marinovich ML, Morrow M: The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 2014; 21: 717–30.

McCahill LE, Single RM, Aiello Bowles EJ et al: Variability in re-excision following breast conservation surgery. JAMA, 2012; 307: 467–75.

Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88(3):553–564.

Morrow M., Van Zee K. J., Solin L. J., Houssami N., Chavez-MacGregor M., Harris J. R., Horton J., Hwang S., Johnson P. L., Marinovich M. L., Schnitt S. J., Wapnir I., Moran M. S., “Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ,” Pract. Radiat. Oncol. 6(5), 287–295 (2016).

Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010. JAMA Surg 2014;149:1296-305.